Walgreens Boots Alliance, Inc. (WBA)
NASDAQ: WBA · Real-Time Price · USD
11.52
+0.01 (0.09%)
At close: Jul 16, 2025, 4:00 PM
11.50
-0.02 (-0.17%)
After-hours: Jul 16, 2025, 7:54 PM EDT
Walgreens Boots Alliance Revenue
Walgreens Boots Alliance had revenue of $38.99B in the quarter ending May 31, 2025, with 7.25% growth. This brings the company's revenue in the last twelve months to $154.58B, up 6.22% year-over-year. In the fiscal year ending August 31, 2024, Walgreens Boots Alliance had annual revenue of $147.66B with 6.17% growth.
Revenue (ttm)
$154.58B
Revenue Growth
+6.22%
P/S Ratio
0.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2024 | 147.66B | 8.58B | 6.17% |
Aug 31, 2023 | 139.08B | 6.38B | 4.81% |
Aug 31, 2022 | 132.70B | 194.00M | 0.15% |
Aug 31, 2021 | 132.51B | 10.53B | 8.63% |
Aug 31, 2020 | 121.98B | 1.91B | 1.59% |
Aug 31, 2019 | Pro | Pro | Pro |
Aug 31, 2018 | Pro | Pro | Pro |
Aug 31, 2017 | Pro | Pro | Pro |
Aug 31, 2016 | Pro | Pro | Pro |
Aug 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
WBA News
- 21 hours ago - Premier Medical Collaborates with Walgreens to Expand Access to Care Across Central Florida - Business Wire
- 2 days ago - Walgreens Takes Major Step Toward Becoming Private Company Again - Forbes
- 5 days ago - Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys - Seeking Alpha
- 5 days ago - Walgreens Shareholders Approve $10 Billion Private Equity Buyout - Forbes
- 5 days ago - Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners - Business Wire
- 8 days ago - Cash Flow Matters: Two Cheap Stocks With Relatively Secure Dividends And Upside Potential - Seeking Alpha
- 20 days ago - Walgreens Outlook Improves As Buyout Faces Shareholder Vote Next Month - Forbes
- 20 days ago - Walgreens Sales Rise but CEO Says Turnaround Will ‘Take Time' - PYMNTS